Incidence, Predictors, and Outcomes of Thrombotic Events in Hospitalized Patients With Viral Pneumonia
Viral pneumonia represents a major cause of morbidity and mortality, especially among older patients.1 Viral pneumonia may be associated with a systemic inflammatory response, which has been linked with arterial and venous thrombotic cardiovascular events.2 During the recent COVID-19 pandemic due to the novel SARS-CoV-2 virus, anecdotal and published experience suggests high rates of thrombotic complications among hospitalized patients.3 Due to a paucity of studies describing the incidence, predictors, and outcomes of thrombotic events among patients with viral pneumonia, the observation of thrombosis in patients with COVID-19 lacks context.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Islam Y. Elgendy, Dhaval Kolte, Michael K. Mansour, Rahul Sakhuja, Sammy Elmariah, Farouc A. Jaffer, Tomas G Neilan, James L. Januzzi, Ido Weinberg, Mazen S. Albaghdadi Source Type: research
More News: Cardiology | Cardiovascular | COVID-19 | Heart | Pandemics | Pneumonia | SARS | Study | Thrombosis